Divis Laboratories Ltd share price logo

Divis' Laboratories Share Price (DIVISLAB)

Check the latest share price of Divis' Laboratories, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹6906.50.44%

as on 04:01PM, 04 Jul 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Divis' Laboratories Stock Performance

Get live Divis' Laboratories share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹6,870
    Day's Price Range
    ₹6,945
  • 52 Week's Low

    52 Week's High

    ₹4,395.3
    52-Week Price Range
    ₹6,945
1 Month Return+ 4.19 %
3 Month Return+ 31.33 %
1 Year Return+ 49.18 %
3 Year Return+ 91.31 %
5 Year Return+ 219.58 %
Previous Close₹6,876.00
Open₹6,880.00
Volume2.43L
Upper Circuit₹7,563.50
Lower Circuit₹6,188.50

Divis' Laboratories Fundamentals & Key Indicators

Check Divis' Laboratories market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹1,83,345.87 Cr

Return on Equity (ROE)

12.04

PE Ratio (TTM)

83.68

Return on capital employed (ROCE)

16.27

Industry PE ratio

54.65

Beta (LTM)

0.76

P/B Ratio

6.75

Dividend Yield

0.87

PEG Ratio

3.76

Quarterly Earnings Growth YOY

23.05

EPS (TTM)

60.38

Sector

Pharmaceuticals

Book Value

512.11

Technical Analysis

How to invest in Divis' Laboratories?

Investing in Divis' Laboratories is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Divis' Laboratories or DIVISLAB on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Divis' Laboratories or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Divis' Laboratories with just a few clicks!

Divis' Laboratories Stock's Interest Amongst Investors

-62.32%

Period Jul 05, 2025 to Jun 05, 2025. Change in 30 Days vs previous period

Investment in Divis Laboratories Ltd Shares on INDmoney has dropped by -62.32% over the past 30 days, indicating reduced transactional activity.

-42%

Period Jul 05, 2025 to Jun 05, 2025. Change in 30 Days vs previous period

Search interest for Divis Laboratories Ltd Stock has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Divis' Laboratories Valuation

Track how Divis' Laboratories P/E has moved over time to understand its valuation trends.

Divis' Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (28.97x)

November 21, 2022

Industry (54.65x)

July 4, 2025

Today (83.68x)

July 4, 2025

Highest (90.48x)

December 4, 2024

LowHigh

Today’s Price to Earnings Ratio: 83.68x

Divis' Laboratories Stock Recommendation

Get updated buy, sell, and hold recommendations by analysts on Divis' Laboratories.

based on 29 analysts

HOLD

39.29%

Buy

25.00%

Hold

35.71%

Sell

39.29% of analysts recommend a 'HOLD' rating for Divis' Laboratories. Average target price of ₹6345.86

Source: S&P Global Market Intelligence

Divis' Laboratories Share Price Target

Get share price movements and forecasts by analysts on Divis' Laboratories.

Divis' Laboratories price forecast by 29 analysts

Downside of-8.12%

High

₹7750

Target

₹6345.86

Low

₹4381

Divis' Laboratories target price ₹6345.86, a slight downside of -8.12% compared to current price of ₹6906.5. According to 29 analysts rating.

Source: S&P Global Market Intelligence

Divis' Laboratories Financial Results

Get the annual and quarterly financial summary of Divis' Laboratories, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

2303 (0%)2118 (8%)2338 (10%)2319 (1%)2585 (11%)
Net Income

(in ₹ Cr)

538 (0%)430 (20%)510 (19%)589 (15%)662 (12%)
Net Profit Margin23.36% (0%)20.30% (13%)21.81% (7%)25.40% (16%)25.61% (1%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

10737 (0%)13329 (24%)14369 (8%)15382 (7%)
Total Liabilities

(in ₹ Cr)

1465 (0%)1638 (12%)1664 (2%)1898 (14%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

1208 (0%)1947 (61%)1910 (2%)2447 (28%)1266 (48%)

Indices Featuring Divis' Laboratories Stock

Check stock indices that include Divis' Laboratories.

S&P BSE SEN. N50

₹85,251.58

0.28 (235.05%)

S&P BSE Momentum

₹2,225.72

-0.41 (-9.27%)

BSE MFG

₹1,039.86

0.14 (1.45%)

Nifty100 Eq Weig

₹33,141.95

0.15 (50.05%)

NIFTY 100

₹26,066.65

0.24 (63.65%)

Nifty Healthcare

₹14,716.10

0.66 (95.9%)

S&P BSE 250 LargeMidCap

₹10,965.76

0.23 (25.08%)

BSE 100

₹26,686.30

0.22 (59.47%)

S&P BSE 100 LargeCap TMC

₹9,401.29

0.22 (20.91%)

BSE Healthcare

₹44,895.66

0.64 (287.55%)

Nifty 500

₹23,562.45

0.17 (40.6%)

Nifty100 Quality

₹5,695.30

0.4 (22.85%)

Nifty 200

₹14,217.15

0.2 (28.55%)

NIFTY PHARMA

₹22,384.60

0.81 (180.35%)

Nifty Next 50

₹68,607.80

0.37 (251.95%)

BSE 200

₹11,561.75

0.23 (26.21%)

Nifty Alpha 50

₹53,449.10

-0.33 (-177.45%)

S&P BSE 100 ESG

₹426.03

0.23 (0.96%)

S&P BSE Dividend Stability

₹1,008.55

0.49 (4.87%)

Nifty LargeMidcap 250

₹16,543.35

0.11 (18.6%)

BSE 500

₹36,967.25

0.21 (76.28%)

S&P BSE Largecap

₹9,805.58

0.23 (22.64%)

Divis' Laboratories Earnings and Dividends

View detailed summary of the earnings and dividend history of Divis' Laboratories.

  • Divis Laboratories Ltd Earnings Results

    Divis Laboratories Ltd’s net profit jumped 23.05% since last year same period to ₹662Cr in the Q4 2024-2025. On a quarterly growth basis, Divis Laboratories Ltd has generated 12.39% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Divis Laboratories Ltd Dividends May,2024

    In the quarter ending March 2024, Divis Laboratories Ltd has declared dividend of ₹30 - translating a dividend yield of 0.43%.

    Read More about Dividends

Divis' Laboratories Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Divis' Laboratories.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
51.89%
0.00
Foreign Institutions
18.01%
0.00
Mutual Funds
12.83%
0.00
Retail Investors
9.39%
0.00
Others
7.88%
0.00

Divis' Laboratories vs Peers

Compare market cap, revenue, PE, and other key metrics of Divis' Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
HOLD1,83,345.8743.92%0.501,6007,845
BUY1,13,983.3037.39%0.671,65610,727
BUY50,811.30-1.08%0.581,29714,755
HOLD30,853.930.58%0.507725,664
BUY1,22,230.4327.69%0.505,29127,547

Divis' Laboratories News & Key Events

Latest news and events in one place to help you make informed investing decisions in Divis' Laboratories.

  • Divis Laboratories Shows Strong Bullish Momentum - 02 Jul, 2025

    Divis Laboratories is experiencing a strong uptrend, with a breakout at Rs 6,800. Analysts suggest potential upside to Rs 7,200, supported by bullish indicators.
  • Divis Laboratories Announces Trading Window Closure - 30 Jun, 2025

    Divis Laboratories Limited has announced the closure of its trading window from July 1, 2025, until 48 hours after its quarterly financial results are released. This is a routine measure to ensure compliance with insider trading regulations.
  • Divis Laboratories Sees RFQs Turning into Projects - 25 Jun, 2025

    Divis Laboratories, along with Syngene and Neuland, has noted that some requests for quotes (RFQs) are being converted into actionable projects, although substantial financial benefits will take time to materialize.
  • Divis Laboratories Gains from Novartis-MSN Patent Settlement - 18 Jun, 2025

    Divis Laboratories' shares are in focus following the settlement between Novartis and MSN regarding the Entresto patent. This development may lead to upward revisions in Divis' financial estimates for FY26 and FY27, depending on future litigation outcomes.
  • Divis Laboratories Continues Upward Trend - 11 Jun, 2025

    Divis Laboratories Ltd is up 1.02% at Rs 6742, marking its third consecutive session of gains. The stock has risen 51.43% over the past year, outperforming both NIFTY and Nifty Pharma index. It has gained 13.46% in the last month, with trading volume at 3.53 lakh shares today.

Insights on Divis Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, DIVISLAB has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 17.99% to 18.01% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 430.0 Cr → 662.0 Cr (in ₹), with an average increase of 13.4% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, DIVISLAB stock has moved up by 17.2%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 2.40K Cr → 2.67K Cr (in ₹), with an average increase of 10.1% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 11.89% to 12.83% in Mar 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 51.89% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 132.9% return, outperforming this stock by 41.6%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 9.59% to 9.39% in Mar 2025 quarter

About Divis' Laboratories

Divis Laboratories Ltd is a leading Indian pharmaceutical company incorporated in 1990. The company specializes in the manufacture of active pharmaceutical ingredients (APIs) and intermediates for the global pharmaceutical market. Divis Laboratories Ltd operates in three lines of business, APIs, Intermediates, and Contract Research and Manufacturing Services (CRAMS).

Divis Laboratories Ltd's top products include APIs and intermediates for anti-infectives, cardiovascular, central nervous system, anti-diabetics, gastro-intestinal and anti-inflammatory treatments. The company is also a leader in the manufacture of custom synthesis and process development services for the global pharmaceutical industry.

Divis Laboratories Ltd is the proud owner of several popular brands, including Divis Life, Divis Pharma and Divis Health. Divis Life offers a range of health and wellness products, while Divis Pharma provides a wide range of APIs, intermediates and custom synthesis services.

Revenue: ₹2,585.00Cr as on March 2025 (Q4 FY25)
Net Profit: ₹662.00Cr as on March 2025 (Q4 FY25)
Listing date: 12 Mar, 2003
Chairperson Name: Ramesh B V Nimmagadda
OrganisationDivis Laboratories Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEORamesh B V Nimmagadda
E-voting on sharesClick here to vote

Mutual Funds that own Divis' Laboratories

Check out the Mutual Funds with significant holdings in Divis' Laboratories.

FAQs

What is Divis' Laboratories share price today?

Divis' Laboratories share price today stands at ₹6906.5, Open: ₹6880, Previous Close: ₹6876, High: ₹6945, Low: ₹6870, 52 Week High: ₹6945, 52 Week Low: ₹4395.3.

What is today's traded volume of Divis' Laboratories?

Today's traded volume of Divis' Laboratories is 2.43L. Which means that 2.43L shares of Divis' Laboratories were bought and sold on the stock market during today's trading session.

What is Divis' Laboratories's market cap today?

Today's market capitalisation of Divis' Laboratories is ₹1,83,345.87 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Divis' Laboratories?

Divis' Laboratories’s 52 week high is ₹6945 and 52 week low is ₹4395.3. The current share price of Divis' Laboratories is ₹6906.5, which is -0.55% down from its 52 week high and 57.13% up from its 52 week low.